Coronary artery bypass surgery hormonal manipulation



==ACCF/AHA Guidelines for Hormonal Manipulation in Patients Undergoing CABG == {{cquote|

Class I
1. Use of continuous intravenous insulin to achieve and maintain an early postoperative blood glucose concentration less than or equal to 180 mg/dL while avoiding hypoglycemia is indicated to reduce the incidence of adverse events, including deep sternal wound infection, after CABG. (Level of Evidence: B)

Class IIb
The use of continuous intravenous insulin designed to achieve a target intraoperative blood glucose concentration less than 140 mg/dL has uncertain effectiveness. (Level of Evidence: B)

Class III: HARM
Postmenopausal hormonal therapy (estrogen/progesterone) should not be administered to women undergoing CABG. (Level of Evidence: B)}}

Guidelines Resources

 * 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery : A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines